Rottendorf Pharma enhances operations with Rockwell Automation's FactoryTalk PharmaSuite MES
16 January 2024 -

Rockwell Automation Inc (NYSE: ROK), an industrial automation and digital transformation company, on Tuesday revealed the adoption of FactoryTalk PharmaSuite MES by Rottendorf Pharma GmbH. This comprehensive electronic batch recording solution promises increased accuracy, quality, efficiency and repeatability, laying the groundwork for future digitalisation endeavors. The deployment aims to optimise day-to-day metrics, multi-customer batch control, and global software validation.

Headquartered in Ennigerloh, Germany, Rottendorf Pharma operates as a global CDMO with expertise in solid-dosage-form production. Embracing Total Process Ownership (TPO) and Total Technological Mastering (TTM) philosophies, the company streamlines customer management, reduces costs and enhances supply chains and product quality.

The deployment of FactoryTalk PharmaSuite MES at Rottendorf Pharma extends beyond operational enhancements, providing consistent weigh-and-dispense data for central weighing operations. This marks the initial step in achieving end-to-end electronic batch recording throughout the pharma value chain.

Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs around 29,000 professionals across more than 100 countries.

Rottendorf Pharma, with over 95 years of experience, offers a diverse portfolio of original and generic drugs, backed by a workforce of over 1,300 experts.